BioCentury | Jan 1, 2021
Targets & Mechanisms

A snapshot of target innovation in 2020

...or partnering include a RAB22A-blocking strategy from a Sun Yat-Sen University...
...Toronto Bright Angel Therapeutics Inc. St. Jude Children's Research Hospital Sun Yat-sen University University...
BioCentury | Dec 31, 2020
Distillery Therapeutics

Agonizing adiponectin receptors to treat NASH, liver fibrosis

...Xu, H. et al. Nat. Commun.; published online Nov. 16, 2020doi:10.1038/s41467-020-19668-yCONTACT: Xianxing Jiang, Sun Yat-sen University, Guangzhou, Chinaemail: jiangxx5@mail.sysu.edu.cn Claire Quang Sun Yat-sen University Adiponectin...
BioCentury | Jul 31, 2020
Distillery Therapeutics

Vesicular trafficking protein fusion targets for metastatic osteosarcoma

...et al. Nat. Cell Biol. ; published online June 1, 2020 doi:10.1038/s41556-020-0522-z CONTACT: Jing-Nan Shen, Sun Yat-Sen University...
...same affiliation as above email: kangtb@sysucc.org.cn CONTACT: Jian Chen, Soochow University, Suzhou, China email: chenjian@cibr.ac.cn Claire Quang Sun Yat-sen University Soochow...
BioCentury | Jun 13, 2020
Translation in Brief

OSE identifies myeloid checkpoint target; plus a call from NCI for COVID-19 test proposals, Sinopharm vaccine data and more

...low doses of BBIBP-CorV in a Chinese Phase I/II trial. Neutrophil extracellular traps promote metastasis Sun Yat-sen University...
...mucin domain 3 BioCentury Staff Oregon Health & Science University University of Kansas Beijing Biological Products Institute (Sinopharm) OSE Immunotherapeutics S.A. Sun Yat-sen University National...
BioCentury | Aug 29, 2019
Distillery Therapeutics

Destabilizing HDGF through NSUN2-YBX1 signaling inhibition for bladder cancer

...Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai, China. email: huangy@sibcb.ac.cn; CONTACT: Dan Xie, Sun Yat-sen University...
...Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China. email: ygyang@big.ac.cn Hongjiang Li Chinese Academy of Sciences Sun Yat-sen University Y...
BioCentury | Jul 20, 2019
Emerging Company Profile

China Ophthalmology Focus eyes Asia market

...Clinical status: Phase III Founded: 2017 by Benjamin Li University collaborators: Hong Kong Polytechnic University, Sun Yat-Sen University...
BioCentury | Jul 19, 2019
Tools & Techniques

A mark up for RNA epigenetics

...that included Gotham SAB member Schraga Schwartz. The other, in Science Advances, came from a Sun Yat-sen University...
...Inc. (NASDAQ:EPZM), Cambridge, Mass. Gotham Therapeutics Corp., New York, N.Y. Storm Therapeutics Ltd., Cambridge, U.K. Sun Yat-sen University...
...Methyltransferase like 3 METTL14- Methyltransferase like 14 Allison Johnson, Senior Writer Accent Therapeutics Inc. Gotham Therapeutics Corp. Storm Therapeutics Ltd. Sun Yat-sen University Weill...
BioCentury | Mar 29, 2019
Targets & Mechanisms

AACR moves in a myeloid direction

...appearing in the top 25 are in Asia: Seoul National University of South Korea and Sun Yat-Sen University...
BioCentury | Dec 4, 2018
Distillery Therapeutics

Infectious disease

...J. et al. Nat. Microbiol. ; published online Dec. 3, 2018 doi:10.1038/s41564-018-0300-x CONTACT: Jianping Wang, Sun Yat-sen University...
...China email: wangjpgz@126.com CONTACT: Xinhua Chen, Harvard Medical School, Boston, Mass. email: xchen1@bidmc.harvard.edu Claire Quang Harvard Medical School Sun Yat-sen University Hypoxia-inducible...
BioCentury | Dec 1, 2018
Politics, Policy & Law

China’s germline growing pain

...Meeting” ). That meeting was triggered by a Protein Cell publication from a group at Sun Yat-sen University...
...OHSU), Portland Ore. Stanford University, Stanford, Calif. Southern University of Science and Technology, Shenzhen, China Sun Yat-sen University...
Items per page:
1 - 10 of 53
BioCentury | Jan 1, 2021
Targets & Mechanisms

A snapshot of target innovation in 2020

...or partnering include a RAB22A-blocking strategy from a Sun Yat-Sen University...
...Toronto Bright Angel Therapeutics Inc. St. Jude Children's Research Hospital Sun Yat-sen University University...
BioCentury | Dec 31, 2020
Distillery Therapeutics

Agonizing adiponectin receptors to treat NASH, liver fibrosis

...Xu, H. et al. Nat. Commun.; published online Nov. 16, 2020doi:10.1038/s41467-020-19668-yCONTACT: Xianxing Jiang, Sun Yat-sen University, Guangzhou, Chinaemail: jiangxx5@mail.sysu.edu.cn Claire Quang Sun Yat-sen University Adiponectin...
BioCentury | Jul 31, 2020
Distillery Therapeutics

Vesicular trafficking protein fusion targets for metastatic osteosarcoma

...et al. Nat. Cell Biol. ; published online June 1, 2020 doi:10.1038/s41556-020-0522-z CONTACT: Jing-Nan Shen, Sun Yat-Sen University...
...same affiliation as above email: kangtb@sysucc.org.cn CONTACT: Jian Chen, Soochow University, Suzhou, China email: chenjian@cibr.ac.cn Claire Quang Sun Yat-sen University Soochow...
BioCentury | Jun 13, 2020
Translation in Brief

OSE identifies myeloid checkpoint target; plus a call from NCI for COVID-19 test proposals, Sinopharm vaccine data and more

...low doses of BBIBP-CorV in a Chinese Phase I/II trial. Neutrophil extracellular traps promote metastasis Sun Yat-sen University...
...mucin domain 3 BioCentury Staff Oregon Health & Science University University of Kansas Beijing Biological Products Institute (Sinopharm) OSE Immunotherapeutics S.A. Sun Yat-sen University National...
BioCentury | Aug 29, 2019
Distillery Therapeutics

Destabilizing HDGF through NSUN2-YBX1 signaling inhibition for bladder cancer

...Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai, China. email: huangy@sibcb.ac.cn; CONTACT: Dan Xie, Sun Yat-sen University...
...Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China. email: ygyang@big.ac.cn Hongjiang Li Chinese Academy of Sciences Sun Yat-sen University Y...
BioCentury | Jul 20, 2019
Emerging Company Profile

China Ophthalmology Focus eyes Asia market

...Clinical status: Phase III Founded: 2017 by Benjamin Li University collaborators: Hong Kong Polytechnic University, Sun Yat-Sen University...
BioCentury | Jul 19, 2019
Tools & Techniques

A mark up for RNA epigenetics

...that included Gotham SAB member Schraga Schwartz. The other, in Science Advances, came from a Sun Yat-sen University...
...Inc. (NASDAQ:EPZM), Cambridge, Mass. Gotham Therapeutics Corp., New York, N.Y. Storm Therapeutics Ltd., Cambridge, U.K. Sun Yat-sen University...
...Methyltransferase like 3 METTL14- Methyltransferase like 14 Allison Johnson, Senior Writer Accent Therapeutics Inc. Gotham Therapeutics Corp. Storm Therapeutics Ltd. Sun Yat-sen University Weill...
BioCentury | Mar 29, 2019
Targets & Mechanisms

AACR moves in a myeloid direction

...appearing in the top 25 are in Asia: Seoul National University of South Korea and Sun Yat-Sen University...
BioCentury | Dec 4, 2018
Distillery Therapeutics

Infectious disease

...J. et al. Nat. Microbiol. ; published online Dec. 3, 2018 doi:10.1038/s41564-018-0300-x CONTACT: Jianping Wang, Sun Yat-sen University...
...China email: wangjpgz@126.com CONTACT: Xinhua Chen, Harvard Medical School, Boston, Mass. email: xchen1@bidmc.harvard.edu Claire Quang Harvard Medical School Sun Yat-sen University Hypoxia-inducible...
BioCentury | Dec 1, 2018
Politics, Policy & Law

China’s germline growing pain

...Meeting” ). That meeting was triggered by a Protein Cell publication from a group at Sun Yat-sen University...
...OHSU), Portland Ore. Stanford University, Stanford, Calif. Southern University of Science and Technology, Shenzhen, China Sun Yat-sen University...
Items per page:
1 - 10 of 53